ch 9-12 Flashcards
abstinence syndrome
condition characterized by unpleasant symptoms after stopping drug use (withdrawal)
allostasis
- adaptive biological process
- response to repeated threats/challenges results in long lasting physiological/ behavioural changes
anhedonia
inability or difficulty to feel joy/pleasure
antireward system
- brain system recruited during addictive stage
- controlled to compulsive use of drug
- amygdala (NE, CRF)
behavioral addiction
uncontrollable behaviors not involving substance use but similar to that seen in substance related disorders
biopsychosocial model
model of addiction attempting to incorporate all factors
breaking point
point at which an organism stops fighting for the reward
candidate gene analysis
analysis of a gene that might be involved with a certain disease
common disease-common variant hypothesis
risk of neuropsychiatric disorders stems from a pool of “risky genes” common in pop.
(each risky allele means increased risk of developing said disease)
common disease-rare variant hypothesis
risk of neuropsychiatric disorders come from rare mutations/genetic anomalies
comorbidity
simultaneous but distinct disease processes
contingency management
treatment of addictions where abstinence from drug is traded for vouchers (services, money etc)
craving
strong urge to take drug
disease model
treat addiction as a disease
drug detoxification
removing drug entirely from body and undergoes withdrawal
drug priming
delivery of small dose of drug to elicit drug-seeking behavior
drug reward
motivating subjective response to drug (euphoria)
∆FosB
- Fos family of transcription factors
- protein accumulates in some brain areas after repeated exposure to certain drugs
- contributes to development of addicted state
electrical self-stimulation
animal self administers a weak electric shock to specific brain area due to its reinforcing effects
executive function
higher order functioning like planning, decision making etc. (largely involves PFC)
gateway theory
use of certain drugs of abuse increases risk of progressing to other substances
genome wide association studies (GWAS)
comparing incidence of SNPs and DNA variants in control vs disease group
heritability
contribution of genetics to variability of a trait
incentive salience
- psychological process
- drug related stimuli gain increased prominence and attractiveness
- important component of incentive- sensitization model of addiction
incentive sensitization theory
repeated drug use increases want for the drug but no increase in liking the drug
(more craving, but no change in reward, bc neural system underlying wanting becomes sensitized)
linkage analysis
genetic analysis of chromosomal regions associated w a disorder
moral model
treats addiction as moral and personal problem
natural recovery
recovery from addiction w/o treatment
neuroadaptations
changes in brain functioning compensating for effects of repeated use
opponent-process model
model of addiction where initial positive response to drug is followed by opposing withdrawal response
place conditioning
pavlovian conditioning resting reward effects
positive reinforcers
smth provided to an organism that increases strength of response to obtain the item (self-admin drug studies)
progressive ratio procedure
method to measure relative power of drug reinforcement by increasing response to reward ratio
reinstatement of drug seeking
restoration of a behavior to obtain drug
relapse
recurrences of drug use after a period of abstinence
remissions
period where an addict is drug free
reward circuit
circuit of neurons mediating rewarding effects
schedule of controlled substances
- system established by substance control act of 1970
- classifies substances with abuse potential into 5 schedules
schedules 1 and 2 are the strictest
self-medication hypothesis
theory that addiction is based on an effort to treat oneself for mood and ill feelings
shared etiology
multiple disorders caused by the same set of factors
single nucleotide polymorphisms
allele variations in a single nucleotide of a gene
(differ from mutations as they have at least 1% prevalence)
substance induced disorders
DSM designations of disorders caused by ingestion of a substance
substance related disorders
DSM category including substance induced disorders and substance use disorders
substance use disorders
DSM designation for psychiatric disorders associated w addiction
acamprosate (Campral)
partial antagonist of NMDA receptor to treat alcoholism
acute tolerance
rapid tolerance formed after single use of drug (like alcohol)
alcohol dehydrogenase
enzyme in liver and stomach that oxidizes alcohol into acetaldehyde
alcohol induced cirrhosis
scar tissue formation promoting cell death as scar tissue cuts off blood supply
alcohol induced hepatitis
death of liver cells, characterized by inflammation of the liver, pain, jaundice, fever
alcohol poisoning
toxic effects of ingesting excess alcohol
- unconsciousness, vomiting, irregular breathing, cold and clammy skin
alcohol use disorder
compulsive alcohol seeking despite damaging social and health effects
association analysis
whether a particular genetic polymorphism is associated w a disease or trait